Who owns Urogen Pharma?
- Ticker: URGN
- CUSIP Number: m96088105
Tip: Access positions for across all investors
Analyze quarterly positions in Urogen Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Urogen Pharma stock
Who bought or sold Urogen Pharma this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 3.1M | $46M | 108% | Dec 2023 |
|
| Dr. Jeffrey R. Jay, M.D. | 2.6M | $39M | 0% | Dec 2023 |
|
| Credit Suisse | 1.2M | $18M | 13% | Dec 2023 |
|
| Harel Insurance Investments & Financial Services | 870k | $13M | 0% | Dec 2023 |
|
| Migdal Insurance & Financial Holdings | 648k | $9.7M | 0% | Dec 2023 |
|
| Millennium Management | 427k | $6.4M | 55% | Dec 2023 |
|
| Opaleye Management | 320k | $4.8M | 0% | Dec 2023 |
|
| Superstring Capital Management | 255k | $3.8M | 100% | Dec 2023 |
|
| Laurion Capital Management | 251k | $3.8M | -34% | Dec 2023 |
|
| Wells Fargo & Company | 219k | $3.3M | 1% | Dec 2023 |
|
| Citadel Advisors | 181k | $2.7M | 325% | Dec 2023 |
|
| Vanguard Group | 171k | $2.6M | 53% | Dec 2023 |
|
| ARK Investment Management | 146k | $2.2M | -9% | Mar 2024 |
|
| AlphaCentric Advisors | 144k | $2.2M | -13% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 132k | $2.0M | 1% | Dec 2023 |
|
| Two Sigma Investments | 131k | $2.0M | 9% | Dec 2023 |
|
| Point72 Asset Management | 126k | $1.9M | -39% | Dec 2023 |
|
| HPM Partners | 125k | $1.9M | 100% | Dec 2023 |
|
| Goldman Sachs Group | 114k | $1.7M | 113% | Dec 2023 |
|
| Wellington Management Company | 105k | $1.6M | 49% | Dec 2023 |
|
| Meitav Dash Investments | 92k | $1.4M | 0% | Dec 2023 |
|
| Annandale Capital | 82k | $1.2M | 0% | Dec 2023 |
|
| D. E. Shaw & Co | 78k | $1.2M | 132% | Dec 2023 |
|
| Bank of America Corporation | 72k | $1.1M | 65% | Dec 2023 |
|
| Rice Hall James & Associates | 70k | $1.1M | 1% | Mar 2024 |
|
| Bank of New York Mellon | 68k | $1.0M | -3% | Mar 2024 |
|
| Charles Schwab Investment Management | 63k | $943k | 36% | Dec 2023 |
|
| Squarepoint Ops | 60k | $895k | 100% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 46k | $690k | 54% | Dec 2023 |
|
| LLBH Private Wealth Management | 38k | $566k | -2% | Dec 2023 |
|
| Barclays | 37k | $560k | 992% | Dec 2023 |
|
| Rhumbline Advisers | 35k | $521k | 29% | Dec 2023 |
|
| Robert Bender & Associates | 35k | $521k | 0% | Mar 2024 |
|
| Jump Financial | 33k | $500k | 13% | Dec 2023 |
|
| Shikiar Asset Management | 33k | $499k | 0% | Mar 2024 |
|
| Marshall Wace | 29k | $428k | 6% | Dec 2023 |
|
| Walleye Trading Advisors | 27k | $408k | 100% | Dec 2023 |
|
| UBS Group | 25k | $376k | 30% | Dec 2023 |
|
| Palo Alto Investors | 25k | $368k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 24k | $359k | 26% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 23k | $345k | 40% | Dec 2023 |
|
| Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet | 22k | $327k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 21k | $308k | 21% | Dec 2023 |
|
| Citigroup | 19k | $280k | 4502% | Dec 2023 |
|
| AQR Capital Management | 18k | $276k | 100% | Dec 2023 |
|
| Two Sigma Advisers | 18k | $275k | -3% | Dec 2023 |
|
| Jane Street | 17k | $249k | 65% | Dec 2023 |
|
| Vivaldi Capital Management | 17k | $309k | 0% | Dec 2023 |
|
| Partners Capital Investment Group | 15k | $231k | 0% | Dec 2023 |
|
| MetLife Investment Advisors | 15k | $219k | 41% | Dec 2023 |
|
| Sierra Summit Advisors | 15k | $218k | 100% | Dec 2023 |
|
| American International | 14k | $203k | 38% | Dec 2023 |
|
| Federated Investors | 12k | $176k | -11% | Dec 2023 |
|
| Mirae Asset Global Investments | 11k | $170k | 1% | Dec 2023 |
|
| Ethos Financial Group | 11k | $158k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 10k | $156k | -1% | Dec 2023 |
|
| SG Americas Securities | 8.7k | $131k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 8.6k | $128k | 0% | Dec 2023 |
|
| Allspring Global Investments Holdings | 5.0k | $74k | 0% | Mar 2024 |
|
| China Universal Asset Management | 3.6k | $54k | 362% | Dec 2023 |
|
| Legal & General Group | 2.9k | $43k | 35% | Dec 2023 |
|
| Summit Investment Advisors | 2.8k | $42k | 74% | Dec 2023 |
|
| Simplex Trading | 2.8k | $42k | -58% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.6k | $24k | 47% | Dec 2023 |
|
| Amalgamated Bank | 943.00 | $14k | -71% | Mar 2024 |
|
| Advisor Group Holdings | 663.00 | $9.9k | -45% | Dec 2023 |
|
| Signature | 616.00 | $9.2k | 670% | Dec 2023 |
|
| Nbc Securities | 437.00 | $6.0k | 100% | Mar 2024 |
|
| Lazard Asset Management | 354.00 | $5.0k | -89% | Dec 2023 |
|
| Russell Investments | 253.00 | $3.8k | 0% | Dec 2023 |
|
| Lindbrook Capital | 160.00 | $2.4k | 158% | Mar 2024 |
|
| Cubist Systematic Strategies | 142.00 | $2.1k | -100% | Dec 2023 |
|
| Us Bancorp | 134.00 | $2.0k | 100% | Dec 2023 |
|
| EverSource Wealth Advisors | 57.00 | $855.000000 | 100% | Dec 2023 |
|
| Quadrant Capital | 56.00 | $840.000000 | 0% | Dec 2023 |
|
| SYSTM Wealth Solutions | 48.00 | $720.000000 | 100% | Mar 2024 |
|
| Daiwa Securities Group | 48.00 | $999.998400 | 0% | Dec 2023 |
|
| CWM | 41.00 | $999.998200 | 100% | Mar 2024 |
|
| GAMMA Investing | 20.00 | $300.000000 | 100% | Mar 2024 |
|
| Farther Finance Advisors | 6.00 | $90.000000 | 100% | Dec 2023 |
|
| Pnc Financial Services | 1.00 | $15.000000 | 100% | Dec 2023 |
|
Who sold out of Urogen Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Soleus Capital Management | Sep 2023 | 372k | $5.2M |
| GSA Capital Partners | Sep 2023 | 10k | $143k |
| Point72 Middle East FZE | Sep 2023 | 5.9k | $83k |
| State of Wyoming | Sep 2023 | 2.0k | $29k |
| Cutler | Dec 2023 | 1.6k | $5.0k |
| Ronald Blue Trust | Sep 2023 | 1.6k | $16k |
| West Tower Group | Sep 2023 | 354.00 | $5.0k |